mRNA technology: Facts and figures

Readingtime 2 minutes

mRNA technologies are revolutionizing medicine. Which diseases are they aimed at? How quickly are the new therapies coming along? And how do the innovative active ingredients enter the body? A numerical overview

publication date7TH JULY 2023

INFOGRAPHIC MAXIMILIAN NERTINGER

Beyond COVID-19
Areas of application of mRNA therapeutics and vaccines1 in clinical development, in percent
Source: Roots Analysis, as of January 2023
¹ Therapeutics for which the status information is available
Oncological disorders
 
Genetic disorders
 
Pulmonary disorders
 
Autoimmune disorders
 
Other disorders
 
mRNA takes off
Start of clinical trials with RNA therapeutics
Source: Beacon Intelligence, as of July 2022
Nanoparticles in the lead
The most important transport systems for mRNA active ingredients by number of product developments
Source: Beacon Intelligence, as of January 2023
Under the skin
Routes of administration of mRNA therapeutics and vaccines, in percent
Source: Roots Analysis, as of January 2023
2 Including intradermal, subcutaneous, and external
Sector pioneers
The most important developers of mRNA therapeutics by number of product developments
Source: Beacon Intelligence, as of July 2022

PUBLICATION DATE

2nd July 2023

Specialty lipids

rPEG lipids: Risk-free delivery

mRNA active ingredients can help in the treatment of numerous diseases. Evonik paves a reliable way for them to enter the body.

Pharma Polymers

How medicine reliably reaches its target

How liposomes play a key role in cancer therapy by transporting ribonucleic acids to the affected cells.

Video

Drug delivery

Transportation via polymers

Evonik and Stanford University are cooperating in a search for new carrier substances for mRNA vaccines.

Vaccination

Reliable Transport

Special protection vehicle: Lipid nanoparticles envelop mRNA vaccines and enable their passage through the cell membrane.

ELEMENTS Newsletter
Get fascinating insights into the research Evonik is conducting, and its social relevance, by subscribing to our free newsletter.